Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
21EP8 Fenbendazole Uncovered: A Journey from Veterinary Staple to Medical Marvel
Fenben® Voices
5 minutes
1 year ago
21EP8 Fenbendazole Uncovered: A Journey from Veterinary Staple to Medical Marvel
Got Questions? Send us a message!Join us on "Fenben Voices" for a captivating exploration into the history of fenbendazole, a drug that transcended its veterinary origins to emerge as a beacon of hope in human health. From its discovery to breakthroughs in human therapy, this episode delves into:The groundbreaking discovery by Hoechst AG.Its rise to prominence in veterinary medicine.The pivotal moments that signaled fenbendazole's potential in human health.The formation of a supportive commun...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
